The strategic refocusing of the animal health specialist on its most promising niches is a success, as evidenced by the annual accounts.
Vetoquinol had already revealed an annual turnover of 521 million euros, gross growth of 21.9% including 13.7% organic. The difference between the two progressions is mainly explained by the integration of Drontal and Profender products. Thus, they contribute 17% to the increase in sales of Essential products, which soared by 34% over the financial year, including an increase of 17% on a like-for-like basis.
All regions where the group operates show strong growth at constant exchange rates. Thus, Europe, the company’s leading market with nearly 50% of billings, is the most dynamic zone (+23.5%), while the Americas account for 22.6% and Asia/ Pacific appreciates by 18%.
A powerful leverage effect on profitability
The acceleration of the company’s industrial activity over the financial year had a positive impact on current operating income. This increased by 54.5% to 100.8 million euros, which brings the corresponding margin to 19.3%, a gain of 4 percentage points.